India, Nov. 5 -- Where is AI delivering the most quantifiable ROI in pharma and biotech today and why are so many pilots failing to scale?

The clearest returns we are seeing today come from two areas: commercial functions and enterprise technology and data operations. AI has moved from promise to proof. In ZS's 2027 CDIO Outlook, 70% of technology leaders report measurable value in enterprise IT, and 56% report it in commercial sales and marketing, from HCP engagement to personalisation. Companies are putting AI to work to improve productivity, make engagement more relevant and run operations more efficiently. But the discipline matters as much as the ambition: the return on any investment comes down to what it costs and the business out...